Depression and Anxiety Trial, Recruiting NCT06080646 Sponsor: San Francisco Veterans Affairs Medical Center Condition: Depression and Anxiety
Back to Depression And Anxiety

Depression and Anxiety Trial, Recruiting

NCT06080646
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People aged 18 to 70 who have been diagnosed with major depressive disorder (MDD), or people in the same age range who have not been diagnosed with MDD (for the comparison group)
  • People who pass a metal screening check to ensure MRI safety
  • People with normal vision, or vision that is fully corrected to normal (for example, with glasses or contact lenses)

Who may not be able to join:

  • People who have had, or currently have, neurological problems — such as seizures or a head injury that caused neurological or thinking/memory problems
  • People who have lost consciousness for more than 30 minutes, or who lost consciousness for any amount of time alongside neurological symptoms
  • People with serious medical conditions, such as seizure disorders, treatment with anti-seizure medications, hormonal (endocrine) disorders, or significant heart problems
  • People who have been dependent on alcohol or other substances within the past year, or whose urine drug test comes back positive on the day of brain imaging
  • People with known claustrophobia (fear of enclosed spaces, such as an MRI scanner)
  • People who are currently pregnant
  • People with an estimated IQ below 70
  • People who have metal in their body, head or neck tattoos, or who are not comfortable inside an MRI scanner (confirm with trial site)
  • People who are unable to attend in-person visits at the research lab in San Francisco (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Susanna L Fryer, PhD, University of California, San Francisco

Phone: 415 221 4810

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
San Francisco Veterans Affairs Medical Center
Registry
ClinicalTrials.gov
Start date
1 June 2021
Est. completion
1 June 2025

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Stimulus preceding negativity; Reward positivity; Late positive potential; fMRI response to win vs. loss reward feedback

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov